ImmuneWorks
About:
ImmuneWorks develops immune tolerance treatments for patients with serious autoimmune diseases in the lung.
Website: http://www.immuneworks.com
Top Investors: BioCrossroads
Description:
ImmuneWorks develops immune tolerance treatments for patients with serious autoimmune diseases in the lung. The company was founded in 2006 to develop safe and effective immune tolerance treatments for patients with serious autoimmune diseases of the lung. The scientific foundation of the company is ImmuneWorks' groundbreaking discovery that antigen-specific autoimmunity is responsible for the disease in over one-half of idiopathic pulmonary fibrosis (IPF) patients. It was incorporated in 2006 and is based in Indianapolis, Indiana.
$735000
$1M to $10M
Indianapolis, Indiana, United States
2006-01-01
info(AT)immuneworks.com
David Wilkes, Ronald Meeusen
1-10
2013-12-26
Private
© 2025 bioDAO.ai